China Pharma Holdings (CPHI) Revenue (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.44 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.78% |
| Dec 31, 2025 | 62.12% |
| Sep 30, 2025 | -26.28% |
| Jun 30, 2025 | -9.73% |
| Mar 31, 2025 | 0.20% |
| Dec 31, 2024 | 3.08% |
| Sep 30, 2024 | 18.94% |
| Jun 30, 2024 | -32.48% |
| Mar 31, 2024 | -36.28% |
| Dec 31, 2023 | 19.20% |
| Sep 30, 2023 | 64.27% |
| Jun 30, 2023 | -43.99% |
| Mar 31, 2023 | -32.89% |
| Dec 31, 2022 | 48.58% |
| Sep 30, 2022 | 21.87% |
| Jun 30, 2022 | 0.57% |
| Mar 31, 2022 | -44.49% |
| Dec 31, 2021 | 46.03% |
| Sep 30, 2021 | -18.09% |
| Jun 30, 2021 | 2.42% |